The Efficacy of Sodium Bicarbonate Ringer's Solution and Lactate Ringer's Solution in Patients Undergoing Long-Term Abdominal Open Surgery: A Multicenter Prospective Randomized Controlled Study.

IF 4.7 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2025-06-01 eCollection Date: 2025-01-01 DOI:10.2147/DDDT.S514725
Susu Zhou, Kai Zhao, Chunmei Liu, Hong Luo, Jun Shi, Chunhong Liu, Xiaoming Li, Fang Gao, Xiangnan Wu, Qin Shen, Wenhua Yuan, Xiaoqing Chai, Xin Wei
{"title":"The Efficacy of Sodium Bicarbonate Ringer's Solution and Lactate Ringer's Solution in Patients Undergoing Long-Term Abdominal Open Surgery: A Multicenter Prospective Randomized Controlled Study.","authors":"Susu Zhou, Kai Zhao, Chunmei Liu, Hong Luo, Jun Shi, Chunhong Liu, Xiaoming Li, Fang Gao, Xiangnan Wu, Qin Shen, Wenhua Yuan, Xiaoqing Chai, Xin Wei","doi":"10.2147/DDDT.S514725","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Sodium bicarbonate Ringer's solution (BRS) is an intravenous fluid that does not rely on hepatic or renal metabolism. It contains bicarbonate ions (HCO<sub>3</sub> <sup>-</sup>) and lacks lactate ions. This study hypothesizes that BRS is more effective in maintaining acid-base balance during prolonged open abdominal surgeries. The aim is to investigate the effects of sodium bicarbonate Ringer's solution on lactate metabolism, acid-base balance, and clinical outcomes in patients undergoing extended-duration open abdominal surgery, with the objective of refining fluid replacement strategies for this patient population.</p><p><strong>Patients and methods: </strong>A multicenter randomized controlled trial was conducted involving 112 patients undergoing open abdominal surgery. Participants were randomly assigned to either the BRS group (n=55) or the lactated Ringer's solution (LRS) group (n=57). The primary outcome was the incidence of postoperative hyperlactacidemia, while secondary outcomes included serum lactate (Lac), pH, base excess (BE), buffered base (BB), bicarbonate (HCO<sub>3</sub> <sup>-</sup>), blood glucose (Glu), electrolytes, postoperative liver and kidney function, and postoperative complications. Linear regression analysis was performed to identify factors influencing lactate concentration.</p><p><strong>Results: </strong>The incidence of hyperlactic acidemia was lower in Group A compared to Group B (9.1% vs 19.3%, <i>P</i> = 0.177), although the difference did not reach statistical significance. No significant differences were observed in lactate (Lac), pH, base excess (BE), bicarbonate (BB), HCO₃⁻, glucose (Glu), or electrolytes between the two groups at any time point (<i>P</i> <sub>time</sub> < 0.001, <i>P</i> <sub>group</sub> > 0.05, <i>P</i> <sub>time * group</sub> > 0.05). Linear regression analysis revealed that diabetes, hypotension and blood loss were significant factors influencing blood lactate concentration <i>(R²</i> = 0.349, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Sodium bicarbonate Ringer's solution and lactate Ringer's solution are both safe options for fluid replacement during long-term open abdominal surgeries. There is no significant difference observed in perioperative lactate levels, acid-base balance, or clinical postoperative outcomes between the two solutions.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"4617-4628"},"PeriodicalIF":4.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140924/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S514725","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Sodium bicarbonate Ringer's solution (BRS) is an intravenous fluid that does not rely on hepatic or renal metabolism. It contains bicarbonate ions (HCO3 -) and lacks lactate ions. This study hypothesizes that BRS is more effective in maintaining acid-base balance during prolonged open abdominal surgeries. The aim is to investigate the effects of sodium bicarbonate Ringer's solution on lactate metabolism, acid-base balance, and clinical outcomes in patients undergoing extended-duration open abdominal surgery, with the objective of refining fluid replacement strategies for this patient population.

Patients and methods: A multicenter randomized controlled trial was conducted involving 112 patients undergoing open abdominal surgery. Participants were randomly assigned to either the BRS group (n=55) or the lactated Ringer's solution (LRS) group (n=57). The primary outcome was the incidence of postoperative hyperlactacidemia, while secondary outcomes included serum lactate (Lac), pH, base excess (BE), buffered base (BB), bicarbonate (HCO3 -), blood glucose (Glu), electrolytes, postoperative liver and kidney function, and postoperative complications. Linear regression analysis was performed to identify factors influencing lactate concentration.

Results: The incidence of hyperlactic acidemia was lower in Group A compared to Group B (9.1% vs 19.3%, P = 0.177), although the difference did not reach statistical significance. No significant differences were observed in lactate (Lac), pH, base excess (BE), bicarbonate (BB), HCO₃⁻, glucose (Glu), or electrolytes between the two groups at any time point (P time < 0.001, P group > 0.05, P time * group > 0.05). Linear regression analysis revealed that diabetes, hypotension and blood loss were significant factors influencing blood lactate concentration (R² = 0.349, P < 0.001).

Conclusion: Sodium bicarbonate Ringer's solution and lactate Ringer's solution are both safe options for fluid replacement during long-term open abdominal surgeries. There is no significant difference observed in perioperative lactate levels, acid-base balance, or clinical postoperative outcomes between the two solutions.

碳酸氢钠林格液和乳酸林格液在长期腹部开放手术患者中的疗效:一项多中心前瞻性随机对照研究。
目的:碳酸氢钠林格液(BRS)是一种不依赖肝脏或肾脏代谢的静脉输液。它含有碳酸氢盐离子(HCO3 -),缺乏乳酸离子。本研究假设BRS在长时间开腹手术中更有效地维持酸碱平衡。目的是研究碳酸氢钠林格液对长时间腹部直视手术患者乳酸代谢、酸碱平衡和临床结果的影响,目的是为这类患者群体改进液体替代策略。患者和方法:对112例腹部开腹手术患者进行多中心随机对照试验。参与者被随机分配到BRS组(n=55)或乳酸林格氏液组(n=57)。主要终点是术后高乳酸血症的发生率,次要终点包括血清乳酸(Lac)、pH、碱过量(BE)、缓冲碱(BB)、碳酸氢盐(HCO3 -)、血糖(Glu)、电解质、术后肝肾功能和术后并发症。通过线性回归分析确定影响乳酸浓度的因素。结果:A组高乳酸血症发生率低于B组(9.1% vs 19.3%, P = 0.177),但差异无统计学意义。在任何时间点,两组之间的乳酸(Lac), pH,碱过量(BE),碳酸氢盐(BB), HCO₃(⁻),葡萄糖(Glu)或电解质没有显著差异(P时间< 0.001,P组> 0.05,P时间* >组0.05)。线性回归分析显示糖尿病、低血压、失血量是影响血乳酸浓度的显著因素(R²= 0.349,P < 0.001)。结论:碳酸氢钠林格氏液和乳酸林格氏液均是长期开腹手术中液体补充的安全选择。两种溶液在围术期乳酸水平、酸碱平衡或临床术后结果方面均无显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信